Shanghai RAAS Blood Products Co., Ltd.
002252
Rank in Stocks
#3635
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Share Price
$0.71007803
Market Cap
$4.68B
Change (1 day)
0.41%
Change (1 year)
-24.40%
Country
CN
Trade Shanghai RAAS Blood Products Co., Ltd. (002252)
Category
Healthcare
P/E ratio for Shanghai RAAS Blood Products Co., Ltd. (002252)
P/E ratio as of October 2026 TTM: 27.04
According to Shanghai RAAS Blood Products Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.04. At the end of 2023 the company had a P/E ratio of 28.30.
P/E ratio history for Shanghai RAAS Blood Products Co., Ltd. from 2005 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 27.04 | 23.60% |
| 2024 | 21.88 | -22.68% |
| 2023 | 28.30 | 24.48% |
| 2022 | 22.73 | -35.99% |
| 2021 | 35.51 | -5.76% |
| 2020 | 37.68 | -39.06% |
| 2019 | 61.83 | -342.18% |
| 2018 | -25.53 | -121.98% |
| 2017 | 116.18 | 66.04% |
| 2016 | 69.97 | -7.83% |
| 2015 | 75.91 | -25.95% |
| 2014 | 102.52 | -70.03% |
| 2013 | 342.08 | 478.18% |
| 2012 | 59.17 | -8.12% |
| 2011 | 64.40 | -36.84% |
| 2010 | 101.96 | 16.73% |
| 2009 | 87.35 | 29.85% |
| 2008 | 67.27 | 10.44% |
| 2007 | 60.91 | 72.06% |
| 2006 | 35.40 | 0.85% |
| 2005 | 35.10 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 28.78 | 6.42% |
US
|
|
| -28.36 | -204.86% |
US
|
|
| -24.57 | -190.84% |
AU
|
|
| - | - |
CH
|
|
| 30.33 | 12.15% |
NL
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.